HTM |
TGF-beta receptor type-2 |
TGFBR2 |
2.8 |
50.0 |
163.2 |
Transforming growth factor |
97 |
136 |
Bonauer et al. 2009,42 Jia et al. 2017,43 Wandzioch and Zaret 2009,44 Xu et al. 2002,45 Zhang et al. 2015.46
|
Agarwal and Agarwal 2018,47 Gabelt and Kaufman 2005,48 Liton et al. 2005;Luna et al. 2011,49 Raghunathan et al. 2015,50 Tamm 2002,51 Wahlig, Lovatt, and Mehta 2018.52
|
|
Transforming growth factor beta receptor type 3 |
TGFBR3 |
2.4 |
12.6 |
13.4 |
|
97 |
136 |
|
|
|
Prostaglandin F2-alpha receptor |
PTGFR |
0.1 |
2.6 |
11.4 |
Prostaglandin |
7 |
105 |
Ludin et al. 2014,60 North et al. 2007,61 Sancilio et al. 2019,62 Wong et al. 2016,63 Zhang et al. 2017.64
|
Barraza, McLaren, and Poeschla 2010,65 Garnock-Jones 2014,66 Hoy 2018,67 Impagnatiello et al. 2019,68 Narayanaswamy et al. 2015.69
|
|
Prostaglandin E2 receptor EP4 subtype |
PTGER4 |
0.3 |
2.5 |
1.0 |
|
7 |
105 |
|
|
|
EGF-like repeat and discoidin I-like domain-containing protein 3 |
EDIL3 |
16.1 |
77.4 |
152.4 |
Integrin |
80 |
46 |
Cheng et al. 2019,70 Jiang et al. 2016,71 Aoyama et al. 1999,72 Kang et al. 2017,73 Mikkola et al. 2003,74 Przybyla, Lakins, and Weaver 2016.75
|
Clark et al. 2013, 76 Faralli, Filla, and Peters 2019,77 Inoue and Tanihara 2013,78 Kwon and Tomarev 2011,79 Yan et al. 2020.80
|
|
Multiple epidermal growth factor-like domains protein 9 |
MEGF9 |
2.3 |
4.4 |
11.5 |
epidermal growth factor |
29 |
7 |
Kratchmarova et al. 2005,81 Moore et al. 1997,82 Nakajima et al. 2007,83 Prabhakaran, Venugopal, and Ramakrishna 2009,84 Zhou et al. 2016.85
|
Acharya et al. 2012,86 Wiederholt, Groth, and Strauss 1998,87 Wordinger et al. 1998.88
|